// App-Quantinova.ai

PB0994 : Validation of the IMPROVE Hospital-Acquired Bleeding Risk Assessment Model in The Medical Inpatients Thrombosis and Hemostasis Study (MITH) Population

Researchers

Presenter

  • K. Wilkinson

Principal Investigators

  • A. Sparks

  • M. Gergi

  • H. Al-Samkari

  • N. Zakai

Medical Centers

  • University of Vermont, Burlington, Vermont, United States

  • Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, United States

  • Chronic Disease Research Group, Minneapolis, Minnesota, United States

  • University of Vermont, COLCHESTER, Vermont, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • National Institutes of Health

Result

  • N/A